NCT01430949View on ClinicalTrials.gov

GENESIS Feasibility Study of the BARD Over-the-Wire Mesh Ablation System for the Treatment of Paroxysmal Atrial Fibrillation

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Paroxysmal Atrial Fibrillation
Interventions
PROCEDURE

Catheter Ablation of Paroxysmal Atrial Fibrillation

Catheter ablation for the treatment of paroxysmal atrial fibrillation. A pulmonary vein isolation procedure will be performed using the OTW MAS and radiofrequency ablation.

Trial Locations (6)

13353

Deutsches Herzzentrum Berlin (DHZB), Berlin

29549

Herz-und Gefässzentrum Bad Bevensen, Bad Bevensen

80636

Herzzentrum Mūnchen, Munich

N6A 5A5

University Hospital, London

L3Y8C3

Southlake Regional Health Centre, Newmarket

W1G 8HP

The Heart Hospital, London

Sponsors

Lead Sponsor

C. R. Bard
All Listed Sponsors
lead

C. R. Bard

INDUSTRY

NCT01430949 - GENESIS Feasibility Study of the BARD Over-the-Wire Mesh Ablation System for the Treatment of Paroxysmal Atrial Fibrillation | Biotech Hunter | Biotech Hunter